TREACE MEDICAL CONCEPTS, INC.
For the period ended Apr 2, 2024. Filed Apr 2, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 2, 2024 · Filed Apr 2, 2024
Contents
SUMMARY COMPENSATION TABLE
| Name and Principal Position · Year · Salary($) · Bonus($) · StockAwards($)(1) · OptionAwards($) (1) · Non-EquityIncentive PlanCompensation($) (2) · All OtherCompensation($) · Total($) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| John T. Treace | 2023 | 684,384 | — | 5,350,966 | 1,977,589 | 393,000 | 16,696 | (3) | 8,422,635 |
| Chief Executive Officer, Director and Founder | 2022 | 568,219 | — | 648,706 | 1,931,854 | 457,000 | 11,470 | 3,617,249 | |
| Mark L. Hair | 2023 | 457,973 | — | 2,987,977 | 1,098,837 | 130,500 | 11,222 | (4) | 4,686,509 |
| Chief Financial Officer | 2022 | 404,109 | — | 228,843 | 680,527 | 213,500 | 10,991 | (4) | 1,537,970 |
| Aaron J. Berutti | 2023 | 365,233 | — | 2,063,917 | 714,218 | 104,000 | 14,990 | (5) | 3,262,358 |
| Senior Vice President, Sales | 2022 | 333,644 | — | 228,843 | 680,527 | 173,000 | 12,771 | (5) | 1,428,785 |
(1)
The amounts reported represent the aggregate grant-date fair value of the restricted stock units, performance-based restricted stock units or stock options awarded to the NEOs, calculated in accordance with ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 11 to our financial statements in our 2023 Annual Report. For purposes of our performance-based restricted stock units, which vest based on the attainment of certain relative total shareholder return metrics (as further described below), the grant date fair value included is based on the probable achievement of such metrics.
(2)
Annual cash incentive amounts for all NEOs in 2023 were paid in March 2024, under our annual cash incentive plan for 2023, as described in the section below entitled "Executive Compensation—Non-Equity Incentive Plan and Bonus Payments for 2023."
(3)
The amount reported in 2023 for Mr. Treace includes $1,311 for life insurance premiums and $15,385 for the Company’s match of Mr. Treace's contributions to our 401(k) plan, which are available to the NEOs on the same basis as other full-time employees.
(4)
The amount reported in 2023 for Mr. Hair includes life insurance premiums of $837 and the Company’s match of his contributions to our 401(k) plan of $10,385.
(5)
The amount reported in 2023 for Mr. Berutti includes life insurance premiums of $421 and the Company’s match of his contributions to our 401(k) plan of $14,569.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.